SGLT2 Inhibitors and the Risk of Pneumonia and Septic Shock SGLT2 Inhibitors and the Risk of Pneumonia and Septic Shock

SGLT2 inhibitors are commonly used in the treatment of type 2 diabetes. Could these agents also help lower the risk of pneumonia and septic shock in these patients?Journal of Clinical Endocrinology & Metabolism
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news